View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Announcing Immuno-Oncology KOL Panel at the JPM Health Week in San Francisco


  • January 9, 2017

  • We are pleased to announce that the IO360 team at the Conference Forum together with BioPharm Insight are co-presenting a panel discussion on Immuno-Oncology: Filtering the Hype for the Next Wave of Targets along side the JP Morgan HealthCare conference. The panel discussion will take place January 9, 2017 at the Chandran Art Gallery in San Francisco. Following the discussion, there will be a networking reception.

     

    Panel Discussion: 5:30 – 6:30 pm

    Immuno-Oncology: Filtering the Hype for the Next Wave of Targets

    Key opinion leaders (KOLs) and industry experts address timely issues in the immuno-oncology field including, but not limited to next-generation I/O therapeutics, check point inhibitors, combinations, pricing and reimbursement expectations, and more.

     

    Panelists:
    Axel_Hoos_new_bw

    Axel Hoos, MD, PhD
    SVP Oncology R&D, GSK and Co-Chair, IO360

     

     

     

    ira-mellman-bw

    Ira Mellman, PhD
    VP, Cancer Immunology, Genentech

     

     

     

    lindee-goh-gw

    Lindee Goh
    Partner, Tapestry Networks

     

     

     

    Omid Hamid BW

    Omid Hamid, MD
    Chief, Translational Research and Immunotherapy / Director, Melanoma Therapeutics, The Angeles Clinic

     

     

    Ramy_Ibrahim_bw

    Ramy Ibrahim, MD
    VP and Head of R&D, Parker Institute for Cancer Immunotherapy

     

     

     

    Moderated by:
    querida_anderson_bw

     

    Querida Anderson
    Editor-in-Chief, BioPharm Insight

     

    Reception 6:30 – 8:30 pm

     

    Registration
    This is a complimentary limited seating event. RSVP is required. To register, please click here.

     

    Venue Information
    chandaran-art-gallery-400-x-171Chandran Art Gallery
    459 Geary Street
    San Francisco, CA 94102

     

     

     

     

     

    * Please note, the panel portion of the event is expected to sell out so register quickly. More attendance will be open for the networking portion of the event.